Santhera Pharmaceuticals Holding AG Stock: price and insider trades · Switzerland
No insider purchase over the last 90 days. The latest, by Anonymous (Executive member of the board of directors / member of senior management), was filed 18 Jan 2024.
Santhera Pharmaceuticals Holding AG: what insiders have been doing
This page follows insider dealings at Santhera Pharmaceuticals Holding AG as filed with SIX SER, a company from the Health Care sector. No insider at Santhera Pharmaceuticals Holding AG has published a filing in the past twelve months. The most recent one dates from 25 June 2024.
Since 2023, the database holds 2 purchases and 1 sale by insiders of the company.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. Every figure here comes from the filings published by SIX SER and describes the past, not future prices; it is not investment advice.
Since the insiders bought
- Anonymous (Executive member of the board of directors / member of senior management)+40.4%Entry CHF 10.00 · Close at T+365 CHF 14.04
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- ▼Anonymous (Executive member of the board of directors / member of senior management)9,036 CHF11SIX1,057 shares@ CHF 8.54872.9% of flowISIN CH1276028821SIX:T1O6P00087
- ▲Anonymous (Executive member of the board of directors / member of senior management)277,493 CHF19SIX30,228 shares@ CHF 9.180.13% mcap91.2% of flowISIN CH1276028821SIX:T1O1I00026Canonical exit: 17 Apr 2024 (T+90)
- ▲Anonymous (Executive member of the board of directors / member of senior management)18,400 CHF12SIX2,000 shares@ CHF 9.200.0082% mcap5.8% of flowISIN CH1276028821SIX:T1N7500025Canonical exit: 3 Oct 2023 (T+90)
3 of 3 declarations
About Santhera Pharmaceuticals Holding AG
Santhera Pharmaceuticals Holding AG is a Swiss biopharmaceutical company focused on developing treatments for rare diseases. It primarily targets muscular and neurological disorders.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
